집중 치료 대상이 아닌 전이성 대장암 환자의 1차 치료에 대한 3상 연구. (SOLSTICE)
집중 치료 후보가 아닌 전이성 결장직장암 환자의 1차 치료에서 베바시주맙과 카페시타빈을 베바시주맙과 병용한 트리플루리딘/티피라실(S 95005)을 비교하는 공개, 무작위, 3상 연구(SOLSTICE 연구)
The main purpose of this study is to demonstrate the superiority of S 95005 in combination with bevacizumab over capecitabine in combination with bevacizumab.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
등록 (실제)
등록
단계
단계
- 3단계
연락처 및 위치
연구 장소
-
-
-
Arnhem, 네덜란드, 6815 AD
- Rijnstate Oncologie
-
Dordrecht, 네덜란드, 3318 AT
- Albert Schweitzer Ziekenhuis Interne Geneeskunde
-
Eindhoven, 네덜란드, 5623 EJ
- Catharina Ziekenhuis Interne Gesneeskunde/Oncologie
-
Rotterdam, 네덜란드, 3083 AN
- Ikazia Ziekenhuis Oncologie
-
Tilburg, 네덜란드, 5022 GC
- ETZ Elisabeth Interne Geneeskunde
-
Uden, 네덜란드, 5406 PT
- Bernhoven Interne Geneeskunde
-
-
-
-
-
Aalborg, 덴마크, 9000
- Aalborg Universitetshospital, Syd Onkologisk Afdelin
-
Copenhagen, 덴마크, 2100
- Rigshospitalet Onkologisk Klinik
-
Herning, 덴마크, 7400
- Regionshospitalet Herning, Hospitalsenheden Vest Onkologisk Afdeling
-
Odense, 덴마크, 5000
- Odense Universitetshospital Onkologisk Afdeling R
-
-
-
-
-
Berlin, 독일, 10707
- Onkologische Schwerpunktpraxis Kurfuerstendamm
-
Lübeck, 독일, 23562
- Lübecker Onkologische Schwerpunktpraxis im Hochschulstadttei
-
München, 독일, 81377
- Klinikum der Universität München Campus Großhadern, Medizinische Klinik und Poliklinik III
-
-
-
-
-
Riga, 라트비아, 1079
- Riga East Univerity Hospital Oncology Centre of Latvia
-
Riga, 라트비아, 1002
- P. Stradins Clinical University Hospital
-
-
-
-
-
Arkhangelsk, 러시아 제국, 163045
- Arkhangelsk Clinical Oncology Dispensary chemotherapy department
-
Krasnodar, 러시아 제국, 350040
- Clinical Oncology Dispensary No.1 Chemotherapy Department
-
Kursk, 러시아 제국, 305524
- Kursk Regional Clinical Oncology Dispensary Oncology Department
-
Moscow, 러시아 제국, 115478
- Russian Cancer Research Center n.a. NN Blokhin Clinical Pharmacology and Chemotherapy
-
Moscow, 러시아 제국, 121467
- University Headache Clinic Outpatient oncology clinic
-
Moscow, 러시아 제국, 143423
- Moscow City Oncology Hospital # 62 chemotherapy department
-
Omsk, 러시아 제국, 644046
- Omsk Clinical Oncologic Dispensary Chemotherapy
-
Pyatigorsk, 러시아 제국, 357502
- Pyatigorsk Interdistrict Oncology Dispensary Chemotherapy department
-
Rostov-on-Don, 러시아 제국, 344037
- Rostov Research Institute of Oncology Chemotherapy department
-
Ryazan, 러시아 제국, 390011
- Regional Clinical Oncology Dispensary
-
Saint Petersburg, 러시아 제국, 115478
- Scientific Centre for Specialized Medical Care (oncological) Chemotherapy
-
Saint Petersburg, 러시아 제국, 197758
- National Medical Research Center of Oncology N.N. Petrova
-
Saint Petersburg, 러시아 제국, 198255
- Saint Petersburg City Oncology Clilnic
-
Samara, 러시아 제국, 443011
- Multidisciplinary clinic "Reaviz"
-
Sochi, 러시아 제국, 354057
- Oncology Dispensary No.2
-
Tomsk, 러시아 제국, 634024
- State Research Institution of Oncology of Tomsk Chemotherapy
-
Yaroslavl, 러시아 제국, 150054
- SBIH of YR "Clinical oncology hospital" chemotherapy department
-
-
-
-
-
Bucharest, 루마니아, 022328
- Institutul Oncologic "Prof Alexandru Trestioreanu" Busuresti Sectia Oncologie Medicala I
-
Bucharest, 루마니아, 030171
- Spitalul Clinic "Coltea" Sectia Oncologie Medicala
-
Cluj-Napoca, 루마니아, 400015
- Institutul Oncologic "Prof. Dr. I. Chiricuta" Cluj Napoca Oncologie Medicala
-
Craiova, 루마니아, 200347
- Centrul de Oncologie Sf Nectarie Oncology Department
-
Craiova, 루마니아, 200385
- S.C Oncolab S.R.L Sectia Oncologie Medicala
-
Iași, 루마니아, 700483
- Institutul Regional de Oncologie Iasi Clinica de Oncologie Medicala
-
Sibiu, 루마니아, 550245
- Spitalul Clinic Judetean de Urgenta Sibiu Sectia Oncologie Medicala
-
Timișoara, 루마니아, 300239
- S.C ONCOMED S.R.L Departament Oncologie Medicala
-
-
-
-
-
Kaunas, 리투아니아, 45434
- Oncology Hospital, Branch of Hospital of Lithuanian Uni. of Health Sciences Kauno klinikos
-
Kaunas, 리투아니아, LT-50161
- Hospital of Lithuania Univ of Health Sciences Kauno klinikos Oncology Institute
-
Klaipėda, 리투아니아, 92288
- Klaipeda University hospital
-
Vilnius, 리투아니아, LT-08660
- National Cancer Institute
-
-
-
-
-
Burgas, 불가리아, 8000
- "Complex oncology center - Burgas" EOOD Department of medical oncology
-
Gabrovo, 불가리아, 5300
- "Multiprofile hosp. for active treatmen Dr. Tota Venkova" AD Department of medical oncology
-
Plovdiv, 불가리아, 4004
- "Complex oncology center - Plovdiv" EOOD, IInd base Dpt. of Med. oncology and onc. diseases in gastroenterology
-
Sofia, 불가리아, 1330
- "Medical Center Nadezhda Clinical" EOOD Medical Oncology Department
-
Sofia, 불가리아, 1431
- "UMHAT Sv. Ivan Rilski" EAD Clinic of clinical hematology, Dpt. of medical oncology
-
Sofia, 불가리아, 1632
- MHAT Serdika EOOD Department of Medical Oncology
-
Sofia, 불가리아, 1756
- Spec. hospital for active treatment of oncology dis. EOOD Department of medical oncology and palliative care
-
Varna, 불가리아, 9003
- SHAT of oncology diseases Dr. Marko Antonov Markov" EOOD Department of medical oncology and palliative therapy
-
Vratsa, 불가리아, 3000
- "Complex Ongology Center - Vratsa" EOOD Department of Medical oncology
-
-
-
-
-
Barretos, 브라질, 14784-400
- Hospital do Câncer de Barretos - Fundação Pio XII Unidade de Pesquisa Clínica
-
Belo Horizonte, 브라질, 30150-320
- Cenantron - Clinica
-
Brasília, 브라질, 70200-730
- Sirio Libanes DF - Centro de Oncologia de Braslia do Sirio- Centro Intergrado de Pesquisa
-
Ijuí, 브라질, 98700-000
- Centro de Pesquisa Hospital de Caridade de Ijuí Unidade de Pesquisa Clínica
-
Porto Alegre, 브라질, 90880-480
- Hospital Mae de Deus Oncologia
-
Salvador, 브라질, 41253-191
- Hospital São Rafael Centro Intergrado de Pesquisa
-
Santo André, 브라질, 09060-870
- CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncol Centro Intergrado de Pesquisa
-
São José do Rio Preto, 브라질, 15090-000
- Hospital de Base Centro Integrado de Pesquisa
-
São Paulo, 브라질, 01246-000
- ICESP - Instituto do Câncer do Estado de São Paulo Centro Integrado de Pesquisa
-
São Paulo, 브라질, 01509-900
- Hospital A C Camargo Unidade de Pesquisa Clinica
-
-
-
-
-
Falun, 스웨덴, 791 82
- Falu Lasarett Onkologmottagningen
-
Jönköping, 스웨덴, 551 85
- Lanssjukhuset Ryhov Onkologiska kliniken
-
Solna, 스웨덴, 171 64
- Karolinska University Hospital, Solna Studiebehandlingsenheten, B8:09
-
Umeå, 스웨덴, 901 85
- Norrlands Universitetssjukhus Cancercentrum Umea
-
Örebro, 스웨덴, 701 85
- Universitetssjukhuset Orebro
-
-
-
-
-
Alicante, 스페인, 03010
- Hospital General Universitario Alicante Servicio de Oncología
-
Badalona, 스페인, 08916
- Hospital Germans Trias i Pujol Unidad de Investigación clínica (UIC) ICO-Oncología medica
-
Barcelona, 스페인, 08035
- H. Valle de Hebrón Servicio de Oncología - (VHIR)
-
Barcelona, 스페인, 08041
- Hospital de la Santa Creu I Sant Pau Oncología Medica
-
Córdoba, 스페인, 14004
- Hospital Uni. Reina Sofía - Hospital Provincial Departamento de Oncología Médica
-
L'Hospitalet de Llobregat, 스페인, 08908
- INSTITUTO CATALAN DE ONCOLOGÍA - ICO Oncología Médica
-
Madrid, 스페인, 28034
- Hospital Universitario Ramón y Cajal, Servicio de Oncologia Médica
-
Madrid, 스페인, 28007
- Hospital Unviersitario Gregorio Marañon Servicio de Oncología Médica
-
Madrid, 스페인, 28040
- H. Clínico San Carlos Servicio de Oncología Médica
-
Madrid, 스페인, 28041
- HOSPITAL 12 DE OCTUBRE Servicio Oncología Médica
-
Madrid, 스페인, 28046
- H. Universitario La Paz Oncología Médica
-
Santander, 스페인, 39008
- Hospital Universitario Marqués de Valdecilla Oncología médica
-
Seville, 스페인, 41013
- H.Virgen Del Rocio
-
Valencia, 스페인, 46010
- Hospital Quirónsalud Valencia Servicio de Oncología Médica
-
Zaragoza, 스페인, 50009
- Hospital Universitario Miguel Servet Servicio de Oncología
-
-
-
-
-
Bratislava, 슬로바키아, 833 10
- Narodny onkologicky ustav Oddelenie klinickej onkologie
-
Košice, 슬로바키아, 04191
- Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie
-
-
-
-
-
Berazategui, 아르헨티나, B1884BBF
- Centro de Oncología e Investigación de Buenos Aires COIBA
-
Buenos Aires, 아르헨티나, C1426ANZ
- Instituto Alexander Fleming
-
Buenos Aires, 아르헨티나, C1093AAS
- Fundación Favaloro Oncology Unit
-
Buenos Aires, 아르헨티나, 1264
- Hospital de Gastroenterología Dr. Carlos Borino Udaondo Oncology Unit
-
Buenos Aires, 아르헨티나, C1431FWO
- Hospital Universitario CEMIC Servicio de Oncología, Unidad de tumores gastrointestinales
-
La Rioja, 아르헨티나, F5300COE
- Centro Oncológico Riojano Integral CORI Fundación CORI para la Investigación y Prevención del Cáncer
-
Mendoza, 아르헨티나, 5500
- Fundación COIR Centro Oncológico de Interación Regional
-
San Miguel de Tucumán, 아르헨티나, T4000IAK
- Centro Médico San Roque
-
Santa Fe, 아르헨티나, S3000FFU
- ISIS Centro especializado
-
Santa Fe, 아르헨티나, S2000KZE
- Instituto de Oncología de Rosario
-
-
-
-
-
Cork, 아일랜드, 90
- Bon Secours Hospital
-
Cork, 아일랜드, T12 DC4A
- Cork University Hospital Department of Medical Oncology
-
Dublin, 아일랜드, D24 NROA
- The Adelaide and Meath Hospital
-
-
-
-
-
Tallinn, 에스토니아, 11312
- East Tallinn Central Hospital Center of Oncology
-
Tallinn, 에스토니아, 13419
- North Estonia Medical Centre Foundation Oncology and Haematology clinic
-
Tartu, 에스토니아, 51014
- Tartu University Hospital, Hematology - Oncology clinic, Radiotherapy and oncological therapy
-
-
-
-
-
Aberdeen, 영국, AB25 2ZN
- Aberdeen Royal Infirmary Oncology Department
-
Bristol, 영국, BS2 8ED
- University Hospitals Bristol Bristol Haematology & Oncology Centre
-
Leeds, 영국, LS9 7TF
- St James's University Hospital
-
Leicester, 영국, LE1 5WW
- Leicester Royal Infirmary The HOPE Clinical Trials Unit
-
London, 영국, SW3 6JJ
- Royal Marsden Hospital Department of Medicine
-
London, 영국, W12 0HS
- Hammersmith Hospital Gary Weston Centre
-
London, 영국, W1G 6AD
- Sarah Cannon Research Institute UK Clinical Trials
-
London, 영국, W6 8RF
- Imperial Healthcare NHS Trust Charing Cross Hospital
-
Manchester, 영국, M20 4BX
- Christie Hospital NHS Foundation Trust GI & Endocrine
-
Rhyl, 영국, LL18 5UJ
- Glan Clwyd Hospital North Wales Cancer Treatment Centre
-
Sutton, 영국, SM2 5PT
- Royal Marsden Hospital Department of Medicine
-
-
-
-
-
Graz, 오스트리아, 8036
- Med. Universität Graz Klinische Abteilung für Onkologie
-
Innsbruck, 오스트리아, 6020
- Medizinische Universität Innsbruck Univ.-Klinik für Innere Medizin V
-
Linz, 오스트리아, 4010
- Ordensklinikum Linz Barmherzige Schwestern Interne I
-
Salzburg, 오스트리아, 5020
- Landeskrankenhaus (SALK) Universitätsklinik für Innere Medizin III (SALK)
-
Sankt Pölten, 오스트리아, 3100
- Universitätsklinikum St. Pölten Klinische Abteilung für Innere Medizin I
-
Vienna, 오스트리아, 1090
- Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie
-
-
-
-
-
Cherkasy, 우크라이나, 18009
- Cherkasy Regional Oncological Dispensary Regional Clinical Oncological Centre
-
Dnipro, 우크라이나, 49055
- Dnipro Regional Oncology Dispensary
-
Dnipro, 우크라이나, 49102
- MI "Dnipropetrovsk City Multi-field Clinical Hospital #4" Department of Oncology
-
Kharkiv, 우크라이나, 61024
- Institute of Medical Radiology of S.P. Grygoryev of AMS UKR
-
Kyiv, 우크라이나, 03022
- National Institute of Cancer Abdominal Oncology Department
-
Kyiv, 우크라이나, 03115
- Kyiv City Clinical Oncology Centre Chemotherapy Department #2
-
Kyiv, 우크라이나, 04107
- Municipal Institution of Kyiv Regional Council "Kyiv Regional Clinical Hospital", proctology department
-
Lviv, 우크라이나, 79031
- Lviv Regional Oncology Center Chemotherapy department
-
Odesa, 우크라이나, 65010
- Odesa Regional Oncology Dispensary Day patient Department
-
Vinnytsia, 우크라이나, 21029
- Podillia Regional Oncology Centre Chemotherapy Department
-
Zaporizhzhya, 우크라이나, 69000
- Regional Clinical Oncological Dispensary Department of Oncology
-
-
-
-
-
Cagliari, 이탈리아, 09100
- Azienda Policlinico Universitaria - Presidio Monserrato Oncologia Medica
-
Cremona, 이탈리아, 26100
- Azienda Socio Sanitaria Territoriale di Cremona ONCOLOGIA
-
Naples, 이탈리아, 80131
- Istituto Nazionale Tumori I.R.C.C.S "Fondazione G. Pascale" Struttura Complessa di Oncologia Medica Addominale
-
Padova, 이탈리아, 35128
- Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1
-
Pisa, 이탈리아, 56126
- A.O.U. Pisana-Ospedale Santa Chiara U.O. di Oncologia Medica 2
-
Potenza, 이탈리아, 85100
- Ospedale San Carlo U.O. Oncologia Medica
-
Reggio Emilia, 이탈리아, 42123
- Arcispedale Santa Maria Nuova Unità di Oncologia
-
Roma, 이탈리아, 00128
- Policlinico Universitario Campus Biomedico UOC di Oncologia Medica
-
Rozzano (MI), 이탈리아, 20089
- Istituto Clinico Humanitas I.R.C.C.S Dipartimento di Oncologia Medica ed Ematologia
-
San Giovanni Rotondo, 이탈리아, 71013
- IRCSS Casa Sollievo della Sofferenza Dipartimento Onco-Ematologia
-
Vicenza, 이탈리아, 36100
- Ospedale S. Bortolo -ULSS8 Berica Distretto Est U.O. ONCOLOGIA
-
-
-
-
-
Brno, 체코, 656 53
- Masarykuv onkologicky ustav Klinika komplexni onkologicke pece
-
Ostrava, 체코
- Fakultni nemocnice Ostrava Klinika onkologicka
-
Prague, 체코, 128 08
- Vseobecna fakultni nemocnice Onkologicka klinika VFN a 1. LF UK
-
Prague, 체코, 140 59
- Thomayerova nemocnice Onkologicka klinika 1. LF UK a TN
-
Prague, 체코, 77900
- Fakultni nemocnice Olomouc Onkologicka klinika
-
-
-
-
-
Almada, 포르투갈, 2805-267
- Hospital Garcia de Orta Serviço de Oncologia Médica
-
Coimbra, 포르투갈, 3000-075
- Centro Hospitalar e Universitário de Coimbra - CHUC Unidade de Inovação e Desenvolvimento (UID)
-
Lisbon, 포르투갈, 1649-035
- Centro Hospitalar Lisboa Norte, Hospital de Santa Maria Serviço de Oncologia Médica
-
Loures, 포르투갈, 2674-514
- Hospital Beatriz Ângelo Serviço de oncologia medic
-
Porto, 포르투갈, 4200-072
- Instituto Português de Oncologia do Porto FG, EPE -IPO Porto Medical Oncology Dept.
-
-
-
-
-
Bialystok, 폴란드, 15-027
- Bialostockie Centrum Onkologii im Marii Curie-Sklodowskiej Oddzial Onkologii Klinicznej im Dr Ewy Pileckiej z pododdzialem Chemioterapii Dziennej
-
Gdansk, 폴란드, 80-952
- Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii
-
Konin, 폴란드, 62-500
- Przychodnia Lekarska "KOMED"
-
Lodz, 폴란드, 93-513
- M. Kopernika Provincial Hospital Oddzial Chemioterapii Nowotworow
-
Olsztyn, 폴란드, 10-228
- SPZOZ MSWiA z Warminsko-Mazurskim Centrum Onkologii Oddzial Kliniczny Onkologii i Immunoonkologii
-
Opole, 폴란드, 45-061
- Opolskie Centrum Onkologii im. Tadeusza Koszarowskiego Oddzial Onkologii Klinicznej
-
Poznan, 폴란드, 61-866
- Wielkopolskie Centrum Onkologii im Marii Sklodowskiej-Curie Oddzial Chemioterapii
-
Tomaszów Mazowiecki, 폴란드, 97-200
- NU-MED Centrum Diagnostyki i Terapii Onkologicznej Tomaszów Mazowiecki II Sp. z o.o., Pododdzial Chemioterapi
-
-
-
-
-
Avignon, 프랑스, 84918
- Institut Sainte Catherine
-
Besançon, 프랑스, 25030
- CHU Jean Minjoz Service d'oncologie médicale
-
Brest, 프랑스, 29200
- CHU Morvan Institut de Cancérologie et d'Hématologie
-
Lyon, 프랑스, 69008
- Hopital Privé Jean Mermoz Service de Gastro entérologie et d'Oncologie médicale
-
Montbéliard, 프랑스, 25209
- Hôpital Nord Franche-Comté - Site du Mittan Service d'oncologie médicale
-
Nice, 프랑스, 06189
- Centre Antoine Lacassagne Dpt d'Oncologie Médicale
-
Paris, 프랑스, 75012
- Hôpital Saint-Antoine Service d'Oncologie Médicale
-
Paris, 프랑스, 75015
- Hôpital Européen Georges Pompidou Oncologie Hépatogastroenterologie-oncologie digestive
-
Pessac, 프랑스, 33604
- Hopital Haut-Leveque Hepato-gastroenterologie et oncologie digestive
-
Toulouse, 프랑스, 31059
- CHU Toulouse Rangueil Oncologie médicale digestive
-
-
-
-
-
Budapest, 헝가리, 1062
- Magyar Honvedseg Egeszsegugyi Kozpont Onkologiai Osztaly
-
Budapest, 헝가리, 1083
- Semmelweis University Radiology and Oncotherapy Clinic
-
Budapest, 헝가리, 1097
- Del-Pesti Centrumkh-Orsz. Hematologiai es Infektologiai Int. Szent Laszlo Telephely
-
Budapest, 헝가리, 1115
- Szent Imre Egyetem Oktatokorhaz Klinikai Onkologia
-
Budapest, 헝가리, 1122
- Orszagos Onkologiai Intezet "B" Belgyogyaszati-Onkologiai O. Es Klin. Farmakologiai O.
-
Budapest, 헝가리, 1145
- Uzsoki Utcai Korhaz Onkoradiologiai Osztaly
-
Debrecen, 헝가리, 4032
- Debreceni Egyetem Orvos es Egeszsegtudomanyi Centrum Onkologiai Intezet
-
Gyula, 헝가리, 57000
- Bekes Megyei Kozponti Korhaz
-
Győr, 헝가리, 9024
- Petz Aladar Megyei Oktato Korhaz Onkoradiologiai Osztaly
-
Kecskemét, 헝가리, 6000
- Bacs-Kiskun Megyei Korhaz Onkoradiologiai Kozpont
-
Nyíregyháza, 헝가리, 4400
- Szabolcs-Szatmar-Bereg Megyei Korhazak Onkoradiologiai Osztaly
-
Pécs, 헝가리, 7624
- Pecsi Tudomanyegyetem, Klinikai Kozpont Onkoterapias Intezet
-
Szeged, 헝가리, 6720
- Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kp. Onkoterápiás Klinika
-
Szolnok, 헝가리, 5004
- JNSZ Megyei Hetenyi Geza Korhaz es Rendelointezet Megyei Onkologiai Centrum
-
Szombathely, 헝가리, 9700
- Markusovsky Egyetemi Oktatokorhaz Onkoradiologiai Osztaly
-
Zalaegerszeg, 헝가리, 8900
- Zala Megyei Korhaz Onkologiai osztaly
-
-
-
-
-
Blacktown, 호주, 2148
- Blacktown Hospital Cancer and Haematology Centre
-
Frankston, 호주, 3199
- Frankston Private Peninsula and Southeast Oncology Group
-
Gateshead, 호주, 2290
- Lake Macquarie Private Hospital
-
Kogarah, 호주, 2217
- St George Hospital St George Hospital Cancer Care Centre
-
Wahroonga, 호주, 2076
- Adventist HealthCare Integrated Cancer Centre
-
Wollongong, 호주, 2500
- Southern Medical Day Care Centre
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
-
Has definitive histologically confirmed adenocarcinoma of the colon or rectum (all other histological types are excluded). Primary tumour localisation must be known.
-
RAS status based on local biological assessment of tumour biopsy must be available. If RAS status is not available at the time of randomisation, tumour biopsy must be available for RAS status determination (based on local biological assessment).
-
Patient is not a candidate for standard full dose combination chemotherapy with irinotecan or oxaliplatin
-
Patient is not a candidate for curative resection of metastatic lesions.
-
No previous systemic anticancer therapy for unresectable metastatic colorectal cancer.
-
ECOG (Eastern Cooperative Oncology Group) performance status ≤2.
-
Adequate organ function (renal, haematological, hepatic, coagulation) as described in the study protocol'
Exclusion Criteria:
-
Pregnancy, breastfeeding or possibility of becoming pregnant during the study.
-
Participation in another interventional study within 4 weeks prior to the randomisation .
-
Patients who have not recovered from clinically relevant non-hematologic CTCAE grade ≥ 3 toxicity of previous anticancer therapy prior to the randomisation.
-
Symptomatic central nervous system metastases.
-
Major surgery within 4 weeks prior to the randomisation.
Exclusion criteria related to S 95005 administration:
-
History of allergic reactions attributed to compounds of similar composition to S 95005 or any of its excipients.
-
Any contraindication present in the SmPC of trifluridine/tipiracil
Exclusion criteria related to bevacizumab administration:
-
Any contraindication present in the SmPC of bevacizumab
Exclusion criteria related to capecitabine administration:
-
Any contraindication present in the SmPC of capecitabine
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: S95005 + 베바시주맙
|
Film-coated tablets of S 95005 (35 mg/m²/dose) will be administered orally twice a day (BID), within 1 hour after completion of morning and evening meals, 5 days on/2 days off, over 2 weeks, followed by a 14-day rest; This treatment cycle will be repeated every 4 weeks. Concentrate for solution for infusion, Bevacizumab (5 mg/kg, IV) administered every 2 weeks (Day 1 and Day 15). This treatment cycle will be repeated every 4 weeks. |
|
활성 비교기: 카페시타빈 + 베바시주맙
|
Film-coated tablets, Capecitabine (1250 mg/m²/dose) will be administered orally BID on Days 1-14 of each cycle. This treatment cycle will be repeated every 3 weeks. Concentrate for solution for infusion, Bevacizumab (7.5 mg/kg, IV) will be administered on Day 1 of each cycle.This treatment cycle will be repeated every 3 weeks. |
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Progression-free Survival (PFS)
기간: Up to 24 months
|
Time elapsed between the randomization and the date of radiological tumour progression (according to RECIST 1.1) or death from any cause. |
Up to 24 months
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
부작용(AE) 발생률
기간: 최대 8년
|
최대 8년
|
|
|
혈액학, 생화학, 응고 및 요검사에서 임상적으로 유의한 변화의 수
기간: 최대 8년
|
최대 8년
|
|
|
ECOG 수행 상태의 변화
기간: 최대 8년
|
최대 8년
|
|
|
혈압, 심박수, 체온 및 체중의 임상적으로 유의한 변화 수
기간: 최대 8년
|
최대 8년
|
|
|
12-리드 ECG 파라미터의 임상적으로 유의한 변화 횟수
기간: 최대 8년
|
최대 8년
|
|
|
Overall Survival (OS)
기간: Up to 8 years
|
Time elapsed between the date of randomization and the date of death due to any cause. |
Up to 8 years
|
|
Overall response rate (ORR)
기간: Up to 8 years
|
The proportion of patients with objective evidence of complete response (CR) or partial response (PR) according to RECIST 1.1 criteria and using investigator's tumour assessment. |
Up to 8 years
|
|
Disease control rate (DCR)
기간: Up to 8 years
|
The proportion of patients with objective evidence of CR or PR or stable disease (SD) according to RECIST 1.1 criteria and using investigator's tumour assessment. |
Up to 8 years
|
|
Duration of response (DoR)
기간: Up to 8 years
|
The time from the first documentation of response (CR or PR) to the first documentation of objective tumour progression or death due to any cause, whichever occurs first. |
Up to 8 years
|
|
Time to treatment failure (TTF)
기간: Up to 8 years
|
The time from randomization to treatment discontinuation for any reason, including disease progression, treatment toxicity, patient preference, or death. |
Up to 8 years
|
|
Quality of life as assessed by EORTC QLQ-C30
기간: Up to 8 years
|
European organization for research and treatment of cancer (EORTC) Quality of Life Questionnaire - Core Questionnaire (QLQ-C30) scores range from 0-100 and assess functional and symptom scores. For functional scores, a higher score represents an increase in functioning. For symptom scores, a higher score represents an increase in symptoms. |
Up to 8 years
|
|
Quality of life as assessed by EQ-5D-5L
기간: Up to 8 years
|
The 5-level EQ-5D version questionnaire scores range from 5 to 25 with a higher score representing a worse health status. |
Up to 8 years
|
공동 작업자 및 조사자
협력자
협력자
수사관
수사관
- 수석 연구원: Thierry ANDRE, PhD, Medical Oncology departement Saint-Antoine hospital (Paris France 75012)
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (실제)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- CL3-95005-006
- 2017 (미국 NIH 보조금/계약)
- 2017-004059-22 (EudraCT 번호)
- U1111-1206-3198 (기타 식별자: UTN)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
Qualified scientific and medical researchers can request access to anonymized patient-level and study-level clinical trial data.
Access can be requested for all interventional clinical studies:
- used for Marketing Authorization (MA) of medicines and new indications approved after 1 January 2014 in the European Economic Area (EEA) or the United States (US).
- where Servier is the Marketing Authorization Holder (MAH). The date of the first MA of the new medicine (or the new indication) in one of the EEA Member States will be considered for this scope.
In addition, access can be requested for all interventional clinical studies in patients:
- sponsored by Servier
- with a first patient enrolled as of 1 January 2004 onwards
- for New Chemical Entity or New Biological Entity (new pharmaceutical form excluded) for which development has been terminated before any Marketing authorization (MA) approval.
IPD 공유 기간
After Marketing Authorisation in EEA or US if the study is used for the approval.
IPD 공유 액세스 기준
Researchers should register on Servier Data Portal and fill in the research proposal form. This form in four parts should be fully documented. The Research Proposal Form will not be reviewed until all mandatory fields are completed.
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
- ICF
- CSR
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
미국에서 제조되어 미국에서 수출되는 제품
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .